{"id":182563,"date":"2015-02-11T17:01:32","date_gmt":"2015-02-11T22:01:32","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/adistem-adult-stem-cells-derived-from-adipose-tissue.php"},"modified":"2015-02-11T17:01:32","modified_gmt":"2015-02-11T22:01:32","slug":"adistem-adult-stem-cells-derived-from-adipose-tissue","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/adistem-adult-stem-cells-derived-from-adipose-tissue.php","title":{"rendered":"AdiStem &#8212; Adult Stem Cells Derived from Adipose Tissue &#8230;"},"content":{"rendered":"<p><p>    Adult Stem Cells (ASCs), by definition, are unspecialized or    undifferentiated cells that not only retain their ability to    divide mitotically while still maintaining their    undifferentiated state but also, given the right conditions,    have the ability to differentiate into different types of cells    including cells of different germ-origin  an ability referred    to as transdifferentiation or plasticity.1,2 In    vitro, the conditions under which transdifferentiation    occurs can be brought about by modifying the culture medium in    which the cells are cultured. In vivo, the same    changes are seen when the ASCs are transplanted into a tissue    environment different to their own tissue-of origin. Though the    exact mechanism of this transdifferentiation of ASCs is still    under debate, this ability of ASCs along with their ability to    self-renew is of great interest in the field of Regenerative    Medicine as a therapeutic tool in being able to regenerate and    replace dying, damaged or diseased tissue.  <\/p>\n<p>    Clinically, however, there are a few criteria that ASCs need to    fulfill before they can be viewed as a viable option in    Regenerative Medicine. These are as follows:3  <\/p>\n<p>      Adds Millions of Stem Cells Back into Circulation.    <\/p>\n<\/p>\n<p>    Adipose Tissue Yields an Abundance of ASCs  <\/p>\n<p>    Compared to any other source, the high concentrations of    regenerative cells found in adipose tissue (depots of fat for    storing energy) especially in the abdominal region, by sheer    volume of availability, ensure an abundance in number of ASCs    ranging in the millions per unit volume. The sheer number    available also has the added advantage of not needing to be    cultured in a laboratory over days in order to get the desired    number of ASCs to achieve what is called therapeutic    threshold i.e. therapeutic benefit. In addition, harvesting    ASCs from adipose tissue through simple, minimally invasive    liposuction under local anesthesia is relatively easier and    painless  and poses minimal risk to the patient compared to    all other possible methods.  <\/p>\n<p>    Adipose tissue ASCs (AT-ASCs) are extremely similar to stem    cells isolated from bone marrow (BMSCs). The similarities in    profile between the two types of ASCs range from morphology to    growth to transcriptional and cell surface phenotypes.4,5 Their    similarity extends also to their developmental behavior both    in vitro and in vivo. This has led to    suggestions that adipose-derived stem cells are in fact a    mesenchymal stem cell fraction present within adipose    tissue.6  <\/p>\n<p>    Clinically, however, stromal vascular fraction-derived AT-ASCs    have the advantage over their bone marrow-derived counterparts,    because of their abundance in numbers  eliminating the need    for culturing over days to obtain a therapeutically viable    number  and the ease of the harvest procedure itself  being    less painful than the harvest of bone marrow. This, in theory,    means that an autologous transplant of adipose-derived ASCs    will not only work in much the same way as the successes shown    using marrow-derived mesenchymal stem cell transplant, but also    be of minimal risk to the patient.  <\/p>\n<p>    AT-ASCs, like BM-ASCs, are called Mesenchymal ASCs because they    are both of mesodermal germ-origin. This means that AT-ASCs are    able to differentiate into specialized cells of mesodermal    origin such as adipocytes, fibroblasts, myocytes, osteocytes    and chondrocytes.7,8,9 AT-ASCs    are also able (given the right conditions of growth factors) to    transdifferentiate into cells of germ-origin other than their    own. Animal model and human studies have shown AT-ASCs to    undergo cardiomyogenic 10, endothelial    (vascular)11, pancreatic (endocrine) 12, neurogenic 13,    and hepatic trans-differentiation14 , while also    supporting haematopoesis15.  <\/p>\n<p>        Low Risk to the    Patient<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the rest here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.adistem.com\/technology\/adipose-derived-adult-stem-cells\/\" title=\"AdiStem -- Adult Stem Cells Derived from Adipose Tissue ...\">AdiStem -- Adult Stem Cells Derived from Adipose Tissue ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Adult Stem Cells (ASCs), by definition, are unspecialized or undifferentiated cells that not only retain their ability to divide mitotically while still maintaining their undifferentiated state but also, given the right conditions, have the ability to differentiate into different types of cells including cells of different germ-origin an ability referred to as transdifferentiation or plasticity.1,2 In vitro, the conditions under which transdifferentiation occurs can be brought about by modifying the culture medium in which the cells are cultured.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/adistem-adult-stem-cells-derived-from-adipose-tissue.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-182563","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/182563"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=182563"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/182563\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=182563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=182563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=182563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}